publication date: Dec. 21, 2010
In this issue:
FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer;
CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints;
ODAC Reviews Post-Marketing Studies for Eight Indications;
Georgetown Sponsors Oncology Agent Development Meeting;
Bush Appoints Kripke To President’s Cancer Panel;
Letter to the Editor
Download (PDF 224KB)
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.